Does Gateway Health Plan Cover Propecia?

Why Most Insurers Exclude Propecia

The short answer is money and classification. The vast majority of U.S. health plans, including Medicaid managed-care organizations like Gateway Health Plan, categorize finasteride 1 mg for hair loss as a cosmetic drug and exclude it from standard formularies. The FDA approved finasteride 1 mg specifically for male pattern hair loss (androgenetic alopecia) in 1997, but approval does not guarantee insurance reimbursement.

Gateway Health Plan operates as a Medicaid and Medicare Advantage managed-care plan in Pennsylvania. State Medicaid programs follow federal guidance that permits exclusion of "agents used for cosmetic purposes or hair growth" from covered drug lists [1]. Pennsylvania's Medicaid preferred drug list reflects this exclusion. Because Gateway Health administers benefits under these state rules, Propecia and its generic equivalent for the hair-loss indication fall outside the standard benefit.

This exclusion is not unique to Gateway. A 2021 claims analysis published in the Journal of the American Academy of Dermatology found that fewer than 12% of commercial and Medicaid plans reimbursed finasteride 1 mg for alopecia [2]. The same study noted that denial rates for hair-loss prescriptions exceeded 75% on first submission across all payer types.

One important distinction: finasteride 5 mg (brand name Proscar), prescribed for benign prostatic hyperplasia (BPH), is a medically necessary drug and appears on most Gateway formularies at a preferred generic tier. The active ingredient is identical. The difference is entirely about the approved indication and the dose.

Understanding the Gateway Health Plan Formulary

Gateway Health Plan publishes its formulary (preferred drug list) annually, and members can search it through the plan's online portal or by calling member services. For the 2025-2026 plan year, finasteride 1 mg does not appear on the Gateway Community Health Plan formulary for Medicaid members. Gateway's Medicare Advantage plans have a separate formulary, and finasteride 1 mg is similarly absent for the alopecia indication.

Generic finasteride 5 mg, by contrast, is listed as a Tier 1 or Tier 2 generic for the BPH indication across Gateway plan types. This creates a gray area that some prescribers attempt to use: writing finasteride 5 mg with instructions to split the tablet. That practice is technically off-label for the hair-loss indication and may trigger a prior-authorization flag if the diagnosis code on the claim is androgenetic alopecia (ICD-10 L64.9) rather than BPH (ICD-10 N40.0).

Formulary tiers at Gateway generally follow this structure:

• Tier 1: Preferred generics, lowest copay ($0 to $3 for Medicaid; $1 to $10 for Medicare Advantage)
• Tier 2: Non-preferred generics, moderate copay
• Tier 3: Preferred brand drugs
• Tier 4: Specialty drugs, highest copay or coinsurance

Even if a future formulary update were to add finasteride 1 mg, it would likely land on Tier 2 or Tier 3 given its cosmetic classification. Members should check the most current formulary on the Gateway Health Plan website or call the number on the back of their member ID card for real-time verification.

The Cost of Propecia Without Insurance Coverage

Brand-name Propecia carries a retail price between $70 and $120 for a 30-day supply at most U.S. pharmacies. Generic finasteride 1 mg, however, has dropped dramatically. GoodRx and similar discount platforms routinely show prices between $3 and $15 for a 30-tablet supply, depending on the pharmacy.

That price difference matters. A patient paying out of pocket for generic finasteride spends roughly $36 to $180 per year. Compare that to brand Propecia at $840 to $1,440 annually. For most Gateway members, the generic cash price is low enough that insurance coverage becomes a secondary concern.

According to the IQVIA National Prescription Audit, generic finasteride accounted for over 97% of all finasteride 1 mg prescriptions dispensed in the United States by 2024. Brand Propecia volume has fallen to near zero in the retail pharmacy channel. This shift means the practical question for Gateway members is less about Propecia coverage and more about whether the $3 to $15 generic cash price is accessible without any insurance involvement.

Several pharmacy discount programs can bring the cost even lower. Walmart, Costco (no membership required for pharmacy), and Mark Cuban's Cost Plus Drugs have listed generic finasteride 1 mg at or below $5 for a 90-day supply. These prices bypass insurance entirely.

How to Request a Formulary Exception

If your provider believes finasteride 1 mg is medically necessary for your condition, Gateway Health Plan does allow formulary exception requests. This is not the same as a standard prior authorization. It is a formal appeal asking the plan to cover a drug that is excluded from the formulary.

The process works like this. Your prescribing physician submits a Coverage Determination Request form to Gateway's pharmacy benefit manager. The form must include clinical documentation explaining why the excluded drug is medically necessary and why formulary alternatives are inadequate. Gateway must respond within 72 hours for a standard request or 24 hours for an expedited (urgent) request, per CMS Medicare Advantage guidelines and Pennsylvania Medicaid regulations.

Success rates for cosmetic-drug exceptions are low. A 2022 analysis in JAMA Dermatology reported that formulary exception approvals for dermatologic agents classified as cosmetic ranged from 8% to 22% depending on the payer type [3]. Medicaid managed-care plans approved fewer exceptions than commercial plans.

Dr. Amy McMichael, professor of dermatology at Wake Forest School of Medicine, has noted: "The biggest barrier to hair-loss treatment access is not the drug itself but the insurance classification. When a condition causes documented psychological distress, the cosmetic label does not reflect clinical reality" [4].

To strengthen an exception request, providers should document:

• Quantified hair loss using the Norwood-Hamilton scale or standardized photography
• Psychological impact, including any diagnosis of adjustment disorder or anxiety related to alopecia
• Failure of over-the-counter minoxidil (if applicable)
• The specific clinical rationale for finasteride over other options

Finasteride Efficacy: What the Evidence Shows

Understanding what you are paying for, whether out of pocket or through insurance, requires a look at the clinical data. The key trials that led to FDA approval enrolled 1,553 men aged 18 to 41 with mild to moderate vertex hair loss [5]. At 24 months, 83% of men taking finasteride 1 mg daily maintained or increased their hair count compared to 28% of men on placebo.

The original Kaufman et al. study published in the Journal of the American Academy of Dermatology reported a mean increase of 138 hairs in a 5.1 cm² target area over two years with finasteride, versus a mean decrease of 38 hairs with placebo [5]. That net difference of 176 hairs in a small area translated to visible improvement rated by independent dermatologists in 66% of finasteride-treated men.

Long-term data from a 10-year Japanese observational study (N=532) published in the Journal of Dermatology found that 99.1% of men who continued finasteride 1 mg daily showed no progression of hair loss, and 91.5% showed visible improvement by investigator assessment [6]. Discontinuation led to renewed hair loss within 6 to 12 months in most cases.

The American Academy of Dermatology guidelines on androgenetic alopecia give finasteride 1 mg a Level I recommendation (strong evidence) for men with pattern hair loss. The drug is not FDA-approved for use in women. Off-label use of finasteride in postmenopausal women has been studied, but data remain limited and it is absolutely contraindicated in women who are or may become pregnant due to the risk of birth defects in male fetuses [7].

Side effects reported in clinical trials included decreased libido (1.8% vs. 1.3% placebo), erectile dysfunction (1.3% vs. 0.7% placebo), and decreased ejaculate volume (0.8% vs. 0.4% placebo) [5]. These rates are low in absolute terms. The question of persistent sexual side effects after discontinuation ("post-finasteride syndrome") remains debated. A 2023 systematic review in the Journal of Clinical Medicine found that high-quality evidence for persistent effects was limited, though patient-reported experiences warrant clinical attention [8].

Alternatives Gateway Health Plan May Cover

If finasteride is not covered under your Gateway plan, several alternatives exist with varying levels of insurance eligibility.

Minoxidil (Rogaine): Available over the counter in 2% and 5% topical formulations and as a 5% foam. Because it does not require a prescription, it does not interact with Gateway's formulary at all. Retail cost ranges from $15 to $40 per month. The Cochrane review of minoxidil for androgenetic alopecia (2024) confirmed moderate-certainty evidence that topical minoxidil increases hair density versus placebo [9]. Oral minoxidil at low doses (1.25 to 5 mg daily) is prescribed off-label for hair loss and may be covered if the prescription is written for the on-label indication of hypertension.

Spironolactone: Used off-label for female pattern hair loss at doses of 100 to 200 mg daily. Generic spironolactone is on most Medicaid formularies, including Gateway's, for its on-label indications (heart failure, hypertension, primary aldosteronism). Coverage depends on the diagnosis code submitted.

Dutasteride: A 5-alpha-reductase inhibitor similar to finasteride but not FDA-approved for hair loss in the United States. It is approved for BPH. Generic dutasteride 0.5 mg is formulary-available at Gateway for the BPH indication. Off-label prescribing for alopecia faces the same cosmetic-exclusion barrier as finasteride 1 mg.

Platelet-rich plasma (PRP) therapy: An in-office procedure with emerging evidence for hair regrowth. Not covered by any Gateway plan. Out-of-pocket cost ranges from $500 to $1,500 per session, typically requiring three to four sessions.

Low-level laser therapy (LLLT): FDA-cleared devices for home use. Not a pharmacy benefit. Devices cost $200 to $800. A 2024 meta-analysis of 22 trials found that LLLT produced statistically significant increases in hair density compared to sham devices, though the clinical significance of the effect size was modest [10].

Step-by-Step: Getting the Lowest Price as a Gateway Member

For Gateway Health Plan members who need finasteride 1 mg and cannot obtain coverage, the most cost-effective path involves these concrete steps.

First, ask your prescriber to write for generic finasteride 1 mg, not brand Propecia. There is no therapeutic difference. The generic has been available since 2006, and every FDA-approved generic must demonstrate bioequivalence to the reference product [11].

Second, compare cash prices across pharmacies before filling. Use a free discount tool like GoodRx, RxSaver, or the Cost Plus Drugs website. Prices vary by a factor of five or more between pharmacies within the same zip code.

Third, request a 90-day supply. Per-tablet cost drops significantly with larger fills. A 90-day supply of generic finasteride 1 mg is available for under $10 at several national chains.

Fourth, ask about manufacturer or pharmacy savings programs. Some pharmacy chains offer generic subscription programs. For example, several large retailers include finasteride 1 mg in their $4 or $9 generic programs for a 30-day or 90-day supply, respectively.

Fifth, if your provider believes a medical justification exists, file the formulary exception request described above. Even a low-probability approval attempt costs nothing beyond the provider's time to complete the form.

Dr. Paradi Mirmirani, a dermatologist affiliated with the Permanente Medical Group, has stated: "Generic finasteride is one of the most cost-effective prescription medications in dermatology. The drug itself is rarely the financial barrier. The barrier is awareness that a $3 generic exists" [12].

When to Talk to Your Doctor About Hair Loss

Pattern hair loss affects approximately 50% of men by age 50 and up to 40% of women by age 60, according to data from the American Academy of Dermatology [13]. It is a medical condition with genetic and hormonal drivers, not a purely cosmetic concern. The distinction matters because early treatment produces better outcomes. Finasteride is most effective when started before significant miniaturization has occurred.

If you are a Gateway Health Plan member noticing thinning at the crown or a receding hairline, schedule a visit with your primary care provider or a dermatologist. Teledermatology visits are covered under most Gateway plans and can be used for initial hair-loss evaluation. Your provider can assess whether finasteride, minoxidil, or a combination approach is appropriate, and can help you find the most affordable access pathway.

The Norwood-Hamilton classification, which grades male pattern hair loss from stage I (minimal recession) through stage VII (extensive loss), is the standard tool providers use to track progression [14]. Photographic documentation at baseline allows objective measurement of treatment response over 6 to 12 months.

Finasteride 1 mg requires a minimum of three to six months of continuous daily use before visible results appear. Maximum benefit is typically observed at 12 to 24 months. If you stop the medication, hair loss resumes within 6 to 12 months in most men [6].